Burning Rock Biotech Ltd (BNR) › Cash & EquivalentsBurning Rock Biotech Ltd (BNR) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: 93.34M CNY2019: 94.23M CNY2020: 1.90B CNY2021: 1.43B CNY2022: 905.45M CNY2023: 615.10M CNY2024: 519.85M CNY2025: 478.39M CNY478.39M CNY2018Cash & Equivalents (CNY)2025Fiscal YearCash & EquivalentsChange YoY2025478.39M CNY-8.0%2024519.85M CNY-15.5%2023615.10M CNY-32.1%2022905.45M CNY-36.7%20211.43B CNY-24.5%20201.90B CNY+1911.3%201994.23M CNY+1.0%201893.34M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share